Who
Steven J. Hamerslag
Director
Company insider
Files Form 4 as: Director, CorVel; Director and 10% owner, Limeade.
In numbers
- Trades disclosed
- 293
- Buys
- 3
- Sells
- 31
- Bought
- $483K
- Sold
- $15.9M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 3 Aug 2006
- Last trade
- 6 Aug 2026
- Last filed
- 10 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Aug 2026filed 10 Aug 2026 | CRVL CorVeloption or derivative · Insurance | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | CRVL CorVeloption or derivative · Insurance | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 13 Feb 2026filed 17 Feb 2026 | CRVL CorVelInsurance | SEC FORM 4 Sold | $484K10,000 at $48.41 | filing |
| 13 Feb 2026filed 17 Feb 2026 | CRVL CorVelInsurance | SEC FORM 4 Sold | $484K10,000 at $48.41 | filing |
| 12 Feb 2026filed 17 Feb 2026 | CRVL CorVelInsurance | SEC FORM 4 Sold | $472K10,000 at $47.17 | filing |
| 12 Feb 2026filed 17 Feb 2026 | CRVL CorVelInsurance | SEC FORM 4 Sold | $472K10,000 at $47.17 | filing |
| 11 Dec 2025filed 15 Dec 2025 | CRVL CorVelInsurance | SEC FORM 4 Code G | —7,000 at $0.00 | filing |
| 7 Aug 2025filed 11 Aug 2025 | CRVL CorVeloption or derivative · Insurance | SEC FORM 4 Code A | —1,500 at $0.00 | filing |
| 6 Feb 2025filed 10 Feb 2025 | CRVL CorVelInsurance | SEC FORM 4 Sold | $1.2M10,000 at $123.48 | filing |
| 1 Aug 2024filed 5 Aug 2024 | CRVL CorVeloption or derivative · Insurance | SEC FORM 4 Code A | —500 at $0.00 | filing |
| 1 Aug 2024filed 5 Aug 2024 | CRVL CorVelInsurance | SEC FORM 4 Sold | $1.1M3,468 at $304.34 | filing |
| 9 Feb 2024filed 9 Feb 2024 | CRVL CorVelInsurance | SEC FORM 4 Sold | $221K927 at $238.21 | filing |
| 9 Feb 2024filed 9 Feb 2024 | CRVL CorVelInsurance | SEC FORM 4 Sold | $244K1,019 at $239.52 | filing |
| 9 Feb 2024filed 9 Feb 2024 | CRVL CorVelInsurance | SEC FORM 4 Sold | $61K255 at $240.27 | filing |
| 9 Feb 2024filed 9 Feb 2024 | CRVL CorVelInsurance | SEC FORM 4 Sold | $104K430 at $241.42 | filing |
| 9 Feb 2024filed 9 Feb 2024 | CRVL CorVelInsurance | SEC FORM 4 Sold | $70K290 at $242.32 | filing |
| 8 Feb 2024filed 9 Feb 2024 | CRVL CorVelInsurance | SEC FORM 4 Sold | $286K1,192 at $239.67 | filing |
| 8 Feb 2024filed 9 Feb 2024 | CRVL CorVelInsurance | SEC FORM 4 Sold | $194K808 at $240.36 | filing |
| 7 Feb 2024filed 9 Feb 2024 | CRVL CorVeloption or derivative · Insurance | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 7 Feb 2024filed 9 Feb 2024 | CRVL CorVeloption or derivative · Insurance | SEC FORM 4 Code M | —3,000 at $0.00 | filing |
News
CorVel (NASDAQ:CRVL) & AdaptHealth (NASDAQ:AHCO) Head-To-Head SurveyCRVL · dailypolitical.com · 24 Oct 2026Comparing InnovAge (NASDAQ:INNV) & CorVel (NASDAQ:CRVL)CRVL · tickerreport.com · 20 Oct 2026Analyzing AdaptHealth (NASDAQ:AHCO) & CorVel (NASDAQ:CRVL)CRVL · themarketsdaily.com · 17 Oct 2026
0 headlines in the last 90 days name Steven J. Hamerslag; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.